Brief: Active Biotech says Q2 operating loss falls to 7.3 MSEK
Aug 9 (Reuters) - Active Biotech AB ACTI.ST says:
* Q2 NET SALES SEK 5.7 MILLION VERSUS SEK 5.1 MILLION YEAR
AGO
* Q2 OPERATING LOSS SEK 7.3 MILLION VERSUS LOSS SEK 23.1
MILLION
YEAR AGO
* Q2 LOSS AFTER TAX SEK 9.1 MILLION
Source text for Eikon: ID:nGNE5fHKcV
Further company coverage: ACTI.ST
(Reporting By Johan Sennero)
((Johan.Sennero@thomsonreuters.com;))
Recent news on Active Biotech AB publ
See all newsBrief: Active Biotech Says Japan Grants Patent For Laquinimod Ophthalmic Formulation
Brief: Active Biotech Reports Q2 Operating Profit Of SEK -10.2 Mln
Brief: Active Biotech Expands U.S. Collaboration
Brief: Active Biotech Gets Approval To Resume Enrolment In Hovon 172 MF Study
Brief: Active Biotech Q1 Loss After Tax At SEK 8.4 Million